Rheumatoid arthritis (RA) is a common autoimmune disease, and approximately 30%-40% of patients develop pulmonary complications such as idiopathic pulmonary fibrosis (IPF), but the causal relationship ...
Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...
Predicting response to durvalumab and olaparib in mTNBC using a novel PD-L1 expression biomarker: A comparison with PD-L1 IHC. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Safety, PK/PD, and efficacy results from Expand-1: A phase 1 dose escalation study of the novel PD-1 targeted IL-2R-βγ agonist sunekafusp alpha (ANV600) as a single agent and in combination with ...
Research in microbiome science has increasingly highlighted the fundamental impact of the gut microbiota on human health, ...
Enhanced features with inbuilt clustering and advanced classifiers with one mouse click. Qlucore, a world leader in the development of bioinformatics software, has today unveiled Qlucore Omics ...
Why change now?: Tumour heterogeneity and multiple biological drivers are challenging single-biomarker approaches in colorectal cancer. New trial designs: Basket, umbrella, and adaptive trials are ...
Key market opportunities in AI for omics studies include the demand for precision medicine, adoption of AI in drug discovery, and AI-powered multi-omics data integration. Emphasis on personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results